| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.0063 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.0086 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |